# AbbVie Inc. (ABBV) — Q4-2024 Earnings Results

**Report date:** 2025-01-31 (before market open)  
**Sector:** Health Care / Biotechnology  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/ABBV/earnings/Q4-2024

## Post-Earnings Brief

### Headline

AbbVie Beats on EPS, Stock Up 4.7%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $2.16 | N/A | +1.27% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Cautiously Optimistic

Overall, management conveyed a positive outlook on their current product lineup. They emphasized the importance of innovation in driving future growth.

**Key quotes:**

> Management highlighted the strength of their pipeline and ongoing product performance.

> They expressed confidence in maintaining market share despite competitive pressures.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

AbbVie's earnings report showed a positive surprise on EPS, which contributed to a 4.7% increase in stock price. The management's comments about their product pipeline and market position suggest they are navigating challenges effectively. However, the lack of revenue data and guidance leaves some uncertainty for investors looking ahead.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/ABBV/earnings/Q4-2024_